Helping to Bring Improved and Novel Therapies to the Right Patient Population Faster
Oncolines offers cell toxicity as an alternative readout for 102 cancer cell panel profiling studies
Oncolines® profiling is the parallel testing of compounds, either small molecules or biologics, on a large panel of human [...]
New insights into the targeting of amino acid-metabolizing enzymes for cancer immunotherapy
Over the recent decades, cancer immunotherapy has emerged as a revolutionary approach to reinvigorate host anti-tumor immunity. However, [...]
Expansion of ResidenceTimer™ kinase panel
Determination of target residence time may help you to differentiate your drug candidate from competitor compounds. Drugs that [...]
Case study – Target identification via Oncolines® profiling and ResidenceTimer™Oncolines®2023-08-22T16:29:47+02:00
